Figure 3

Percentage of surviving mice following challenge with indicated amounts of ArtAB over time. BALB/c mice (n = 5–8) were challenged with graded doses of ArtABs (ArtAB-DT104, ArtAB-SW, or ArtAB-Sb) and observed daily over a 2-week period.